Half of pharma launches miss first-year targets. AI models analyzing millions of data points in real time are cutting stockouts by 75%, reducing inventory costs by 55%, and delivering 80%+ forecast accuracy for specialty drugs.
AI in Specialty Drug Demand Forecasting: From Missed Targets to Measurable Results Read More »
More than 85% of biopharma executives are investing in AI supply chain tools in 2025. AI models analyse demand, logistics, and geopolitical signals in real time to reduce carrying costs, prevent stockouts, and accelerate time-to-market. One top-10 pharma company projects saving 1 billion dollars over five years through AI-driven optimisation.
How AI Is Cutting Supply Chain Costs Across Biotech Read More »
TechCrunch reported that Harvey acquired Hexus on 2026-01-23.
The report described intensifying competition in legal tech.
Biotech legal teams: Harvey’s acquisition is a real signal Read More »
The pharma gross-to-net bubble reached $356 billion in 2024, driven by rebates, chargebacks, and distributor fees. AI tools now enable real-time GTN monitoring, smarter distributor demand forecasting, and dynamic channel pricing. Companies adopting these approaches report 9% margin expansion and 17% better tender win rates.
How AI Closes the $356 Billion Distributor Margin Gap in Biotech Read More »
Unitree held a boxing match between two G1 humanoid robots at the BattleBots Arena during CES 2026.
The robots wore headgear and gloves, fought under a human referee, and were reported to cost about $13,500 each.
Unitree stages G1 humanoid robot boxing match at CES Read More »
University of Illinois researchers introduced Stomata In-Sight to observe stomata opening and closing in real time.
The system measures carbon dioxide and water vapor flow through leaves while imaging stomata.
Stomata In-Sight watches leaf pores breathe in real time Read More »
More than 85% of biopharma executives are investing in AI supply chain tools in 2025. AI models analyse demand, logistics, and geopolitical signals in real time to reduce carrying costs, prevent stockouts, and accelerate time-to-market. One top-10 pharma company projects saving 1 billion dollars over five years through AI-driven optimisation.
How AI Is Cutting Supply Chain Costs Across Biotech Read More »
